Dihydroergotamine recalls

The FDA has published 1 recall involving Dihydroergotamine since 2024. The latest was reported on 25 Dec 2024. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2024

Last 12 months0reported

Class I00% of total

Ongoing1latest 25 Dec 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 1 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why dihydroergotamine is recalled

Other Reasons1100%

Companies

Provepharm1100%

By year

20241100%

Ongoing dihydroergotamine recalls

1 active

Reported	Class	Recall	Company	Reason	Where
25 Dec 2024Drug	CLASS II	Dihydroergotamine Mesylate Injection, solution recalled by ProvepharmDihydroergotamine Mesylate	Provepharm	Other	Nationwide

All dihydroergotamine recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
25 Dec 2024Drug	CLASS II	Dihydroergotamine Mesylate Injection, solution recalled by ProvepharmDihydroergotamine Mesylate	Provepharm	Other	Nationwide

Should you stop taking Dihydroergotamine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.